Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
NCT Number: NCT02639208
The number of patients 60 and older with breast cancer is increasing as our population ages. Despite the fact that the majority of breast cancers occur in patients 60 and over, these patients are consistently under-represented in clinical trials. Because patients 60 and older are an under-studied group, investigators do not have detailed information on the side effects and experiences for these patients receiving chemotherapy. Understanding the side effects patients receiving chemotherapy experience is an important part of this study.
In addition, past research has shown that having poor social support can affect quality of life, mood, and outcomes for people with cancer. However, few studies in the past have focused on improving the quality of life and support systems that patients have while they receive treatment.
This research study is evaluating how engaging in an online support community may improve the experience of older patients receiving chemotherapy.
Looking for future studies?
Notify Me60 year and older
Female
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
This clinical trial will evaluate how an on-line health information sharing community of patients called PatientsLikeMe, www.patientslikeme.com, [or "PLM"] may help patients feel better supported during treatment. This study will also evaluate how much PLM can help collect information on side effects from chemotherapy and endocrine treatments, and radiation therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4-6 months
We will describe the degree of patient use of the PLM platforms and the associations of short and longer term PLM use with patient characteristics
Time frame: 6 Months
Usability (how useful they found PLM, what parts of the site they used, etc.) will be assessed using a patient experience survey at the end of the study
Time frame: 6 Months
Satisfaction with the PLM experience wil be assessed using a 'patient experience' survey at the end of the study
Time frame: 6 Months
Desirability (how much they enjoyed using PLM, etc) wil be assessed using a patient experience survey at the end of the study
Dana-Farber Cancer Institute
Other
Improving Support for Older Patients Receiving Neo/Adjuvant Chemotherapy for Breast Cancer Using a Novel Social Media Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05528263
Acupuncture, Breast Cancer Stage I
Boston, Massachusetts, United States
View Trial DetailsNCT06771635
Behavior, Breast Cancer Stage I
Burgos, Spain
View Trial DetailsNCT05190770
Breast Cancer, Breast Cancer Stage
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05180656
Breast Cancer, Breast Cancer Stage I
Toronto, Ontario, Canada
View Trial Details